|

MicroRNA as Markers in Testicular Cancer

RECRUITINGSponsored by Haukeland University Hospital
Actively Recruiting
SponsorHaukeland University Hospital
Started2016-12-31
Est. completion2026-12-31
Eligibility
Age18 Years – 70 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04914026

Summary

The main objective of this study is establish the performance of miR371 in management of testicular cancer

Eligibility

Age: 18 Years – 70 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Patients with suspected testicular cancer, referred to orchiectomy.
* Patients diagnosed with testicular germ cell cancer.
* Age 18-70 years of age.
* Must be able receive information and to consent.

Exclusion Criteria:

* Other prior or concomitant malignancy (other than testicular cancer).
* Other diseases or conditions that hinder the ability to receive information and to participate in follow-up procedures.

Conditions9

CancerNon-Seminoma Testicular CancerRelapse Testicular CancerSeminomaStage I Testicular CancerStage II Testicular CancerStage III Testicular CancerStage IV Testicular CancerTesticular Germ Cell Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.